{"listing":{"listing_type":"company","name":"Acta Pharmaceuticals","slug":"acta-pharmaceuticals","tagline":"Alzheimer's therapies for early intervention and prevention, led by gamma-secretase modulator research","description":"Acta Pharmaceuticals, Inc. is a Boston biotech translating Alzheimer's research pioneered by scientific founder Dr. Rudolph E. Tanzi into clinical candidates for early intervention and prevention. Its lead program, GSM-779690T, is an oral gamma-secretase modulator in a Phase 1 healthy-volunteer study. In October 2026 the company announced closing $24 million in seed financing to advance the pipeline, alongside a combination-therapies discovery effort based on Alzheimer's-in-a-Dish models.","url":"https://actapharmaceuticals.com/","is_stealth":false,"normalized_domain":"actapharmaceuticals.com","normalized_url_key":"actapharmaceuticals.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://actapharmaceuticals.com/wp-content/uploads/2026/10/ACTA-Logo-26-FIN.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/acta-pharmaceuticals","platform":"linkedin"},{"label":"Funding announcement","url":"https://www.biospace.com/press-releases/acta-pharmaceuticals-closes-24-million-in-seed-financing-for-alzheimers-disease-pipeline-targeting-early-intervention-and-prevention"},{"label":"ClinicalTrials.gov","url":"https://clinicaltrials.gov/study/NCT07690228"}],"entry_points":[{"kind":"homepage","url":"https://actapharmaceuticals.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://actapharmaceuticals.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[{"name":"Rudolph E. Tanzi","role":"Scientific Founder","person_slug":"rudolph-e-tanzi-08macy2crbbz6","bio":null,"location":null,"links":[]},{"name":"George Alex","role":"Co-founder and CEO","person_slug":"george-alex-3gf4y8gl8xgyq","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"4b04d244-23da-4884-9262-5e34accafa91"},"categories":["Biotech","Healthcare","Pharmaceuticals","Alzheimer's"],"stage":"seed","founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/acta-pharmaceuticals","contact_email":null,"added_at":"2026-10-16T04:26:23.693Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-16T04:26:23.693Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"alzheimers","name":"Alzheimer's","note":null,"profile_url":"/industries/alzheimers"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"pharmaceuticals","name":"Pharmaceuticals","note":null,"profile_url":"/industries/pharmaceuticals"}]}}